Early results from randomized phase III trial of imatinib mesylate for gastrointestinal stromal tumors.

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)273
Number of pages1
JournalCurrent oncology reports
Volume5
Issue number4
DOIs
StatePublished - Jul 2003

ASJC Scopus subject areas

  • Oncology

Cite this